{"doi":"10.1002/clc.23448","title":"Is race or ethnicity associated with under‐utilization of statins among women in the United States: The study of women's health across the nation","abstract":"BACKGROUND: Rates of statin use among minority women are unclear. HYPOTHESIS: We hypothesized that statin use would vary by race/ethnicity with lower rates among minority women compared with Whites. METHODS: Data from the study of women's health across the nation, a multiethnic cohort of women collected between 2009 to 2011 were used to examine reported statin use by race/ethnicity and risk profile. Multivariable logistic modeling was performed to estimate the odds ratio (OR) of statin treatment. RESULTS: Of the 2399 women included, 234 had a diagnosis of atherosclerotic disease (ASCVD), 254 were diabetic (without ASCVD), 163 had an LDL ≥190 mg/dL, and 151 had a 10 year ASCVD pooled risk score ≥7.5%. Statins were used by 49.6% of women with CVD; 59.8% of women with diabetes without known ASCVD; 42.3% of women with an LDL ≥190 mg/dL; and 19.9% of women with an ASCVD risk ≥7.5%. Rates of statin use were 43.8% for women with ≥ two prior ASCVD events and 69.4% for women with ≥ one prior ASCVD event plus multiple high-risk conditions. Among women eligible for statins, Black women had a significantly reduced adjusted odds of being on a statin (OR 0.53, 95% confidence interval [CI] 0.36-0.78) compared with White women. CONCLUSIONS: In this cohort of multiethnic women, rates of statin use among women who would benefit were low, with Black women having lower odds of statin use than White women.","journal":"Clinical Cardiology","year":2020,"id":77519,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":19,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9302,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2020-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":341543,"name":"Kristine Ruppert","orcid":"0000-0002-3008-6584","position":1,"is_corresponding":false},{"id":388827,"name":"Carol A. Derby","orcid":"0000-0002-5657-4519","position":2,"is_corresponding":false},{"id":405581,"name":"Yinjuan Lian","orcid":null,"position":3,"is_corresponding":false},{"id":405582,"name":"Claudia U. Chae","orcid":null,"position":4,"is_corresponding":false},{"id":404035,"name":"Rasa Kazlauskaite","orcid":"0000-0001-9877-5522","position":5,"is_corresponding":false},{"id":405583,"name":"Genevieve Neal‐Perry","orcid":null,"position":6,"is_corresponding":false},{"id":309258,"name":"Samar R. El Khoudary","orcid":"0000-0003-2913-0821","position":7,"is_corresponding":false},{"id":230374,"name":"Sioḃán D. Harlow","orcid":"0000-0002-9899-356X","position":8,"is_corresponding":false},{"id":391215,"name":"Daniel H. Solomon","orcid":"0000-0001-8202-5428","position":9,"is_corresponding":false},{"id":377000,"name":"Elizabeth A. Jackson","orcid":"0000-0002-5086-0418","position":0,"is_corresponding":true}],"reference_count":38,"raw_metadata":null,"created_at":"2026-07-18T21:49:16.197289Z","pmid":"32862481","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}